Long-Term Study Evaluating The Long-Term Safety And Tolerability Of Once Daily Centanafadine Capsules In Children And Adolescents With Attention-Deficit/Hyperactivity Disorder
Posted Date: Feb 7, 2022
- Investigator: Luis Patino Duran
- Specialties: ADD/ADHD, Adolescent Psychiatry/Psychology
- Type of Study: Drug
Long-term Safety of Centanafadine in Children and Adolescents With Attention-deficit/Hyperactivity Disorder
Criteria:
Males And Females Aged 4 To 17 Years
Keywords:
Adhd, Attention, Kids
For More Information:
Bhavana Ramachandran
(513) 558-4413
ramachba@ucmail.uc.edu